{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:02:28Z","timestamp":1792929748316,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["912043"],"award-info":[{"award-number":["912043"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["911775"],"award-info":[{"award-number":["911775"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1502-8","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:04:22Z","timestamp":1558105462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1186","volume":"16","author":[{"given":"Kjetil","family":"B\u00e5rdsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cato","family":"Brede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Kvivik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Terje","family":"Kval\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Jonsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Bolette","family":"Tjensvoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ruoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roald","family":"Omdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"1502_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/00019052-199612000-00011","volume":"9","author":"LB Krupp","year":"1996","unstructured":"Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol. 1996;9:456\u201360.","journal-title":"Curr Opin Neurol"},{"key":"1502_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/acr.22720","volume":"68","author":"T Karageorgas","year":"2016","unstructured":"Karageorgas T, Fragioudaki S, Nezos A, Karaiskos D, Moutsopoulos HM, Mavragani CP. Fatigue in primary Sj\u00f6gren's syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations. Arthritis Care Res (Hoboken). 2016;68:123\u201331.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1502_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","volume":"45","author":"LC Pollard","year":"2006","unstructured":"Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford). 2006;45:885\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1502_CR4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/rheumatology\/kew008","volume":"55","author":"K Br\u00e6kke Norheim","year":"2016","unstructured":"Br\u00e6kke Norheim K, Imgenberg-Kreuz J, Jonsdottir K, Janssen EAM, Syv\u00e4nen A-C, Sandling JK, Nordmark G, Omdal R. Epigenome-wide DNA methylation patterns associated with fatigue in primary Sj\u00f6gren\u2019s syndrome. Rheumatology. 2016;55:1074\u201382.","journal-title":"Rheumatology"},{"key":"1502_CR5","doi-asserted-by":"crossref","unstructured":"B\u00e5rdsen K, Nilsen MM, Kval\u00f8y JT, Norheim KB, Jonsson G, Omdal R. Heat shock proteins and chronic fatigue in primary Sj\u00f6gren\u2019s syndrome. Innate Immunity. 2016.","DOI":"10.1177\/1753425916633236"},{"key":"1502_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","volume":"37","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of fatigue. Trends Neurosci. 2014;37:39\u201346.","journal-title":"Trends Neurosci"},{"key":"1502_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633\u201352.","journal-title":"Nat Rev Drug Discov"},{"key":"1502_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"1502_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123\u201337.","journal-title":"Neurosci Biobehav Rev"},{"key":"1502_CR10","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720\u201332.","journal-title":"Blood"},{"key":"1502_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1749-6632.1997.tb48395.x","volume":"823","author":"KW Kelley","year":"1997","unstructured":"Kelley KW, Hutchison K, French R, Bluth\u00e9 R-M, Parnet P, Johnson RW, Dantzer R. Central interleukin-1 receptors as mediators of sickness. Ann N Y Acad Sci. 1997;823:234\u201346.","journal-title":"Ann N Y Acad Sci"},{"key":"1502_CR12","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.1073\/pnas.1205207109","volume":"109","author":"J Qian","year":"2012","unstructured":"Qian J, Zhu L, Li Q, Belevych N, Chen Q, Zhao F, Herness S, Quan N. Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase. Proc Natl Acad Sci U S A. 2012;109:12189\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1502_CR13","doi-asserted-by":"publisher","first-page":"18048","DOI":"10.1523\/JNEUROSCI.4067-11.2011","volume":"31","author":"Y Huang","year":"2011","unstructured":"Huang Y, Smith DE, Ibanez-Sandoval O, Sims JE, Friedman WJ. Neuron-specific effects of interleukin-1beta are mediated by a novel isoform of the IL-1 receptor accessory protein. J Neurosci. 2011;31:18048\u201359.","journal-title":"J Neurosci"},{"key":"1502_CR14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bbi.2009.06.151","volume":"23","author":"E Harboe","year":"2009","unstructured":"Harboe E, Tjensvoll AB, Vefring HK, G\u00f8ransson LG, Kval\u00f8y JT, Omdal R. Fatigue in primary Sj\u00f6gren's syndrome--a link to sickness behaviour in animals? Brain Behav Immun. 2009;23:1104\u20138.","journal-title":"Brain Behav Immun"},{"key":"1502_CR15","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1073\/pnas.1118748109","volume":"109","author":"J Lampa","year":"2012","unstructured":"Lampa J, Westman M, Kadetoff D, Agr\u00e9us AN, Le Ma\u00eetre E, Gillis-Haegerstrand C, Andersson M, Khademi M, Corr M, Christianson CA, et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci U S A. 2012;109:12728\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1502_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-004-0463-z","volume":"25","author":"R Omdal","year":"2005","unstructured":"Omdal R, Gunnarsson R. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis - a pilot study. Rheumatology International. 2005;25:481\u20134.","journal-title":"Rheumatology International"},{"key":"1502_CR17","doi-asserted-by":"publisher","first-page":"e30123","DOI":"10.1371\/journal.pone.0030123","volume":"7","author":"KB Norheim","year":"2012","unstructured":"Norheim KB, Harboe E, G\u00f8ransson LG, Omdal R. Interleukin-1 inhibition and fatigue in primary Sj\u00f6gren\u2019s syndrome--a double blind, randomised clinical trial. PLoS One. 2012;7:e30123.","journal-title":"PLoS One"},{"key":"1502_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.2337\/dc11-1196","volume":"34","author":"C Cavelti-Weder","year":"2011","unstructured":"Cavelti-Weder C, Furrer R, Keller C, Babians-Brunner A, Solinger AM, Gast H, Fontana A, Donath MY, Penner IK. Inhibition of IL-1\u03b2 improves fatigue in type 2 diabetes. Diabetes Care. 2011;34:2011.","journal-title":"Diabetes Care"},{"key":"1502_CR19","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.24311","volume":"59","author":"B Segal","year":"2008","unstructured":"Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, Patel K, Novitzke J, Rohrer M, Gopalakrishnan R, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sj\u00f6gren's syndrome. Arthritis Rheum. 2008;59:1780\u20137.","journal-title":"Arthritis Rheum"},{"key":"1502_CR20","doi-asserted-by":"publisher","first-page":"11376","DOI":"10.1523\/JNEUROSCI.2311-11.2011","volume":"31","author":"AJ Grossberg","year":"2011","unstructured":"Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG Jr, Marks DL. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011;31:11376\u201386.","journal-title":"J Neurosci"},{"key":"1502_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 11","key":"1502_CR22","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1002\/acr.20579","volume":"63","author":"S Hewlett","year":"2011","unstructured":"Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S263\u201386.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1502_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000395074","volume":"7","author":"AT Beck","year":"1974","unstructured":"Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151\u201369.","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"1502_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"2006","unstructured":"Ware JE, Sherbourne CD. The MOS 36-ltem Short-Form Health Survey (SF-36). Medical Care. 2006;30:473\u201383.","journal-title":"Medical Care"},{"key":"1502_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.mp.4002055","volume":"13","author":"I Goshen","year":"2008","unstructured":"Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13:717\u201328.","journal-title":"Mol Psychiatry"},{"key":"1502_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acps.12656","volume":"134","author":"P Ellul","year":"2016","unstructured":"Ellul P, Boyer L, Groc L, Leboyer M, Fond G. Interleukin-1\u03b2-targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatr Scand. 2016;134:469\u201384.","journal-title":"Acta Psychiatr Scand"},{"key":"1502_CR27","unstructured":"Norheim K, Alexsson A, Imgenberg-Kreuz J, Brun JG, Jonsson R, Ng W-F, Theander E, Mandl T, Sivils KL, R\u00f6nnblom L, et al. Genetic Determinants of fatigue in primary Sj\u00f6gren\u2019s syndrome - a genome-wide association study. Arthritis Rheumatol. 2017;69."},{"key":"1502_CR28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","volume":"83","author":"H Tilg","year":"1994","unstructured":"Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994;83:113\u20138.","journal-title":"Blood"},{"key":"1502_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell. 1999;97:889\u2013901.","journal-title":"Cell"},{"key":"1502_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/cmi.2016.34","volume":"14","author":"D Bertheloot","year":"2017","unstructured":"Bertheloot D, Latz E. HMGB1, IL-1\u03b1, IL-33 and S100 proteins: Dual-function alarmins. Cell Mol Immunol. 2017;14:43\u201364.","journal-title":"Cell Mol Immunol"},{"key":"1502_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5501\/wjv.v4.i2.42","volume":"4","author":"KM Lee","year":"2015","unstructured":"Lee KM. New advances on glial activation in health and disease. World J Virol. 2015;4:42.","journal-title":"World J Virol"},{"key":"1502_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991\u20137.","journal-title":"Nat Med"},{"key":"1502_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469\u201374.","journal-title":"Neuron"},{"key":"1502_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2869.2011.00943.x","volume":"21","author":"HA Droogleever Fortuyn","year":"2012","unstructured":"Droogleever Fortuyn HA, Fronczek R, Smitshoek M, Overeem S, Lappenschaar M, Kalkman J, Renier W, Buitelaar J, Lammers GJ, Bleijenberg G. Severe fatigue in narcolepsy with cataplexy. J Sleep Res. 2012;21:163\u20139.","journal-title":"J Sleep Res"},{"key":"1502_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrn3837","volume":"15","author":"T Sakurai","year":"2014","unstructured":"Sakurai T. The role of orexin in motivated behaviours. Nat Rev Neurosci. 2014;15:719\u201331.","journal-title":"Nat Rev Neurosci"},{"key":"1502_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11910-016-0700-3","volume":"16","author":"KG Burfeind","year":"2016","unstructured":"Burfeind KG, Yadav V, Marks DL. Hypothalamic dysfunction and multiple sclerosis: implications for fatigue and weight dysregulation. Curr Neurol Neurosci Rep. 2016;16:98.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1502_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbi.2013.11.003","volume":"37","author":"KB Weymann","year":"2014","unstructured":"Weymann KB, Wood LJ, Zhu X, Marks DL. A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun. 2014;37:84\u201394.","journal-title":"Brain Behav Immun"},{"key":"1502_CR38","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/0269881111408954","volume":"26","author":"P Bettica","year":"2012","unstructured":"Bettica P, Nucci G, Pyke C, Squassante L, Zamuner S, Ratti E, Gomeni R, Alexander R. Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist. J Psychopharmacol. 2012;26:1058\u201370.","journal-title":"J Psychopharmacol"},{"key":"1502_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbadis.2010.11.003","volume":"1812","author":"S Zhan","year":"2011","unstructured":"Zhan S, Cai GQ, Zheng A, Wang Y, Jia J, Fang H, Yang Y, Hu M, Ding Q. Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination. Biochim Biophys Acta. 2011;1812:565\u201371.","journal-title":"Biochim Biophys Acta"},{"key":"1502_CR40","first-page":"91","volume":"9","author":"T Yokoyama","year":"1998","unstructured":"Yokoyama T, Oda M, Seino Y. Interleukin-1 beta and interleukin-1 receptor antagonist levels in cerebrospinal fluid of aseptic meningitis patients. Pediatr Allergy Immunol. 1998;9:91\u20136.","journal-title":"Pediatr Allergy Immunol"},{"key":"1502_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0169-328X(94)90197-X","volume":"27","author":"S Laye","year":"1994","unstructured":"Laye S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res. 1994;27:157\u201362.","journal-title":"Brain Res Mol Brain Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1502-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1502-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1502-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T23:16:03Z","timestamp":1589584563000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1502-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1502"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1502-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"6 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed according to the Declaration of Helsinki and approved by the Regional Ethics Committee West (2010\/1455). All participants gave written consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"102"}}